Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study

BACKGROUND: We describe early dissemination patterns for first-line bevacizumab given for metastatic colorectal cancer treatment. METHODS: We analyzed patient surveys and medical records for a population-based cohort with metastatic colorectal cancer treated in multiple regions and health systems in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafar, S Yousuf, Malin, Jennifer L, Grambow, Steven C, Abbott, David H, Schrag, Deborah, Kolimaga, Jane T, Zullig, Leah L, Weeks, Jane C, Fouad, Mona N, Ayanian, John Z, Wallace, Robert, Kahn, Katherine L, Ganz, Patricia A, Catalano, Paul, West, Dee W, Provenzale, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174931/
https://www.ncbi.nlm.nih.gov/pubmed/21846341
http://dx.doi.org/10.1186/1471-2407-11-354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174931/
https://www.ncbi.nlm.nih.gov/pubmed/21846341
http://dx.doi.org/10.1186/1471-2407-11-354

Ejemplares similares